Financial Updates for the Psychedelics Industry | Page 8 of 9 | Microdose

Psychedelics News

Finance

30 Mar 2022

ATAI Announces Fourth Quarter and Full Year 2021 Results

With the sector in the midst of a (very) extended pullback, these results provide opportunities to re-focus our attention on the details of the company’s progress and away from the...

By Jason Najum

Finance

28 Mar 2022

MindMed Reports 2021 Financial and Business Results

It’s always big news when MindMed is in the headlines....

By Jason Najum

Finance

10 Mar 2022

Albert Labs Begins Trading on the CSE

The psychedelic medicine industry has a new player....

By Jason Najum

Finance

7 Mar 2022

Cathie Wood Continues to Buy More ATAI Stock

ARK is doubling down on its psychedelic bet, showing that it believes in the innovative potential of the sector....

By Jason Najum

Join Our Newsletter for Exclusive Updates, Stories, and More

Finance

3 Feb 2022

New Psychedelic ETF Launches on the NASDAQ

Despite a tough half-year in the market, the launching of a new ETF on the prestigious NASDAQ exchange is positive news for the industry....

By Jason Najum

Finance

20 Jan 2022

Eleusis: New Psychedelic Player Coming to the NASDAQ

Private firm Eleusis to go public on NASDAQ with upcoming merger...

By Microdose

Finance

14 Jan 2022

Psychedelic Stocks to Watch in 2022

While 2022 hasn’t yet given us the market turnaround we had hoped for, the forthcoming 12 months will filled with clinical trial news and significant milestones....

By Jason Najum

Finance

19 Nov 2021

A Look at Small Cap Psychedelic Firms: Part 3

Small cap firms offer interesting potential opportunities for investors, so to help you stay informed we’ve put together a list of some of the top small cap companies....

By Jason Najum

Breaking News, Finance

12 Nov 2021

Positive Industry News for Cybin and Others Post-Wonderland

As the psychedelic medicine industry emerges from its collective post-Wonderland afterglow, we find a stream of positive industry news waiting for us on our feeds....

By Jason Najum

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result